HanchorBio Secures Approval for TWSE Innovation Board Listing, Aiming for Global Expansion HanchorBio has announced its upcoming listing on the TWSE Innovation Board, aiming to boost clinical development and strengthen institutional partnerships.

HanchorBio Secures Approval for TWSE Innovation Board Listing, Aiming for Global Expansion #Taiwan #Taipei #biotech_company #HanchorBio #TWSE_Innovation_Board

Brii Biosciences Reports Major Developments and 2025 Financial Results Brii Biosciences has released its 2025 financial results and updates on its HBV treatment strategies, showcasing advancements in drug development and discovery.

Brii Biosciences Reports Major Developments and 2025 Financial Results #USA #Durham #Brii_Biosciences #HBV_Treatment #biotech_company

Nuevocor Welcomes Dr. Thierry Abribat to its Board of Directors Nuevocor, a Singapore biotech firm, announces the appointment of Dr. Thierry Abribat to its Board, enhancing its leadership in gene therapy for cardiomyopathies.

Nuevocor Welcomes Dr. Thierry Abribat to its Board of Directors #Singapore #Nuevocor #biotech_company #Thierry_Abribat

Zymo Research is Revolutionizing Domestic Solutions for Biosciences During Supply Chain Disruption Zymo Research emerges as a leading provider of reliable U.S.-based solutions, addressing supply chain challenges for research and diagnostics.

Zymo Research is Revolutionizing Domestic Solutions for Biosciences During Supply Chain Disruption #United_States #Irvine #NGS_solutions #Zymo_Research #biotech_company

Recmed Secures $12.9 million in Funding through FUNDINNO PLUS+ Service Japanese biotech company Recmed has raised approximately $12.9 million via FUNDINNO PLUS+, highlighting significant investment trends in the sector.

Recmed Secures $12.9 million in Funding through FUNDINNO PLUS+ Service #Japan #Machida #FUNDINNO #biotech_company #Recmed

Spyre Therapeutics Offers Stock Options Under Inducement Awards to Employees Spyre Therapeutics, a biotech firm, has granted stock options to three new employees as part of their equity inducement strategy, enhancing employee retention.

Spyre Therapeutics Offers Stock Options Under Inducement Awards to Employees #United_States #Spyre_Therapeutics #IBD_treatment #Waltham #biotech_company